Search
for
Sort by
Research 31–60 of 811
- 25 years of ERβ: a personal journey
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Recent Progress of Dopamine-Modified Tissue Adhesives for Biomedical Applications in Underwater Environments
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
- Hair loss due to aripipirazole use: a case report
- Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of Allopregnanolone in Adult Male Rats
- Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice
- Successful management of minoxidil toxicosis in a dog
- Male Sex Hormones in Andrology Today
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Trichotillomania as a Manifestation of Dementia
- Minoxidil Overdose: A Case Report and Review of the Literature
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- Activation of extrasynaptic δ-GABAA receptors globally or within the posterior-VTA has estrous-dependent effects on consumption of alcohol and estrous-independent effects on locomotion
- ς<sub>1</sub>Receptor-Related Neuroactive Steroids Modulate Cocaine-Induced Reward
- Tumour Necrosis Factor Alpha, Interferon Gamma and Substance P Are Novel Modulators of Extrapituitary Prolactin Expression in Human Skin
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward.
- Direct Vasodilators and Sympatholytic Agents
- The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development
- Androgenic disorders
- Cardiometabolic profile of young women with hypoprolactinemia
- Parkinson's disease and skin
- Choice of treatment for women with polycystic ovary syndrome
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?
- Effect of inhibiting prolactin secretion on secondary hair follicle development in cashmere goats
- Poster Abstracts